Differential regulation of glycosphingolipid biosynthesis in phenotypically distinct Burkitt's lymphoma cell lines

No abstract is available for this paper.

• Publication year

  1995

• Venue

  International Journal of Cancer

• Publication date

  1995-04-10

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/ijc.2910610220PMID 7705957
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Sequential changes in glycolipid expression during human B cell differentiation: enzymatic bases.

  1995cited by this paper
• Apoptosis induced in Burkitt's lymphoma cells via Gb3/CD77, a glycolipid antigen.

  1993cited by this paper
• Biological roles of oligosaccharides: all of the theories are correct

  1993cited by this paper
• Variable subcellular localization of glycosphingolipids.

  1993cited by this paper
• Sequential shifts in the three major glycosphingolipid series are associated with B cell differentiation.

  1991cited by this paper
• Cell phenotype dependent expression of MHC class I antigens in Burkitt's lymphoma cell lines.

  1991cited by this paper
• Induction of bcl-2 expression by Epstein-Barr virus latent membrane protein 1 protects infected B cells from programmed cell death.

  1991cited by this paper
• Activation of Epstein–Barr virus latent genes protects human B cells from death by apoptosis

  1991cited by this paper
• CD77: an antigen of germinal center B cells entering apoptosis

  1991cited by this paper
• Different Epstein-Barr virus-B cell interactions in phenotypically distinct clones of a Burkitt's lymphoma cell line.

  1990cited by this paper
• The pathogenesis of Burkitt's lymphoma.

  1990cited by this paper
• Bifunctional role of glycosphingolipids. Modulators for transmembrane signaling and mediators for cellular interactions.

  1990cited by this paper
• Neutral glycosphingolipids of the globo-series characterize activation stages corresponding to germinal center B cells.

  1990cited by this paper
• ABH and Related Histo‐Blood Group Antigens; Immunochemical Differences in Carrier Isotypes and Their Distribution 1

  1989cited by this paper
• A phenotypic study of cells from burkitt lymphoma and ebv‐b‐lymphoblastoid lines and their relationship to cells in normal lymphoid tissues

  1989cited by this paper
• Downregulation of cell adhesion molecules LFA-3 and ICAM-1 in Epstein- Barr virus-positive Burkitt's lymphoma underlies tumor cell escape from virus-specific T cell surveillance

  1988cited by this paper
• Identification of a subset of normal B cells with a Burkitt's lymphoma (BL)-like phenotype.

  1987cited by this paper
• Intracellular localization of lactosylceramide, the major human neutrophil glycosphingolipid.

  1987cited by this paper
• Subpopulations of B lymphocytes in germinal centers.

  1987cited by this paper
• Differences in B cell growth phenotype reflect novel patterns of Epstein‐Barr virus latent gene expression in Burkitt's lymphoma cells.

  1987cited by this paper
• Endemic Burkitt's lymphoma: phenotypic analysis of tumor biopsy cells and of derived tumor cell lines.

  1986cited by this paper
• Epstein‐Barr virus status and tumour cell phenotype in sporadic Burkitt's lymphoma

  1986cited by this paper
• Distinctions between endemic and sporadic forms of epstein‐barr virus‐positive burkitt's lymphoma

  1985cited by this paper
• Early events in Epstein-Barr virus infection provide a model for B cell activation

  1985cited by this paper
• Enzymatic and organizational difference in expression of a Burkitt lymphoma-associated antigen (globotriaosylceramide) in Burkitt lymphoma and lymphoblastoid cell lines.

  1984cited by this paper
• Glycosphingolipids as differentiation-dependent, tumor-associated markers and as regulators of cell proliferation

  1984cited by this paper
• Characterization of tumor-associated ganglio-N-triaosylceramide in mouse lymphoma and the dependency of its exposure and antigenicity on the sialosyl residues of a second glycoconjugate.

  1983cited by this paper
• Glycosphingolipids as tumor-associated and differentiation markers.

  1983cited by this paper
• Factors affecting expression of glycolipid tumor antigens: influence of ceramide composition and coexisting glycolipid on the antigenicity of gangliotriaosylceramide in murine lymphoma cells.

  1983cited by this paper
• Glycolipid markers of murine lymphocyte subpopulations.

  1978cited by this paper
• Quantitative isolation of total glycosphingolipids from animal cells.

  1971cited by this paper
• Isolation of brain strandin, a new type of large molecule tissue component.

  1951cited by this paper

• Finding the Sweet Spot for the Treatment of B Cell Malignancies

  2025influential citation
• Proteomic analysis unveils Gb3-independent alterations and mitochondrial dysfunction in a gla−/− zebrafish model of Fabry disease

  2023cites this paper
• The choanoflagellate pore-forming lectin SaroL-1 punches holes in cancer cells by targeting the tumor-related glycosphingolipid Gb3

  2022cites this paper
• A pore-forming β-trefoil lectin with specificity for the tumor-related glycosphingolipid Gb3

  2022cites this paper
• Extracellular Proton Concentrations Impacts LN229 Glioblastoma Tumor Cell Fate via Differential Modulation of Surface Lipids

  2017cites this paper
• Intracellular trafficking of AIP56, a bacterial AB toxin trageting NF - kB

  2015cites this paper
• UDP-Gal: Lactosylceramide Alpha 1,4-Galactosyltransferase (A4GALT)

  2014cites this paper
• Bacterial Superantigens : Too Much of a Good Thing

  2013cites this paper
• A Ribosome-inactivating Protein Toxin as a Template for Cancer Drug Discovery

  2012cites this paper
• severe combined immunodeficient mice Shiga-like toxin purges human lymphoma from bone marrow of

  2011cites this paper
• The Yin and Yang of lactosylceramide metabolism: implications in cell function.

  2008cites this paper
• Murine glycosyltransferases responsible for the expression of globo-series glycolipids: cDNA structures, mRNA expression, and distribution of their products.

  2005cites this paper
• Cellular Effects of Bacterial Toxins: Implications for Foodborne Illness

  2004cites this paper
• CD77 (Globotriaosyl Ceramide) and Verotoxin

  2002cites this paper
• Shiga-Like Toxins as Targeted Anticancer Agents

  2002cites this paper
• The use of Shiga-like toxin 1 in cancer therapy.

  2001cites this paper
• Cloning and expression of the histo-blood group Pk UDP-galactose: Ga1beta-4G1cbeta1-cer alpha1, 4-galactosyltransferase. Molecular genetic basis of the p phenotype.

  2000cites this paper
• Cloning and Expression of the Histo-blood Group PkUDP-galactose:Galβ1–4Glcβ1-Cer α1,4-Galactosyltransferase

  2000cites this paper
• Verotoxin targets lymphoma infiltrates of patients with post-transplant lymphoproliferative disease.

  2000cites this paper
• Molecular Cloning of Globotriaosylceramide/CD77 Synthase, a Glycosyltransferase That Initiates the Synthesis of Globo Series Glycosphingolipids*

  2000cites this paper
• The B Subunit of Shiga Toxin Fused to a Tumor Antigen Elicits CTL and Targets Dendritic Cells to Allow MHC Class I-Restricted Presentation of Peptides Derived from Exogenous Antigens1

  2000cites this paper
• Transcriptional repression of the human galactocerebrosidase gene in squamous cell carcinomas of the larynx

  1999cites this paper
• Bacterial toxins: friends or foes?

  1999cites this paper
• Verotoxin/Globotriaosyl Ceramide Recognition: Angiopathy, Angiogenesis and Antineoplasia

  1999cites this paper
• Tissue inhibitor of metalloproteinase (TIMP)-1 induces differentiation and an antiapoptotic phenotype in germinal center B cells.

  1998cites this paper
• CD77‐dependent retrograde transport of CD19 to the nuclear membrane: Functional relationship between CD77 and CD19 during germinal center B‐cell apoptosis

  1998cites this paper
• Shiga-like toxin purges human lymphoma from bone marrow of severe combined immunodeficient mice.

  1996cites this paper